Re transitioning from R&D to commercial supplier of devices. Watch Cramer interview with AS from mid 2011. Its scary how the language is all the same and (thanks REM) we wait.
The company cant seem to put their finger on when exactly they will be transitioning and the claimed 20million a year CAPEX is starting to look massively underdine
- Forums
- ASX - By Stock
- UNS
- agm voting
agm voting, page-32
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online